The Journal of Headache and Pain is affiliated with the European Headache Federation and Lifting the Burden.
Improvements in pain, medication use and quality of life in onabotulinumtoxinA-resistant chronic migraine patients following erenumab treatment – real world outcomes
The CGRP antagonists offer a novel therapeutic approach in migraine. Their utility in patients with severe forms of chronic migraine is a subject of particular interest. We present outcomes of 9 months of eren...
Citation: The Journal of Headache and Pain 2021 22:5